Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

Chronic respiratory diseases are the third leading cause of death, behind cardiovascular diseases and cancer, affecting approximately 550 million of people all over the world. Most of the chronic respiratory diseases are attributable to asthma and chronic obstructive pulmonary disease (COPD) with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchinetti, Fabrizio, Civelli, Maurizio, Singh, Dave, Papi, Alberto, Emirova, Aida, Govoni, Mirco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650159/
https://www.ncbi.nlm.nih.gov/pubmed/34887752
http://dx.doi.org/10.3389/fphar.2021.740803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650159/
https://www.ncbi.nlm.nih.gov/pubmed/34887752
http://dx.doi.org/10.3389/fphar.2021.740803

Ejemplares similares